Pharmacovigilance Practices by Healthcare Providers in Oncology: A Cross-Sectional Study

• Egile Nagusiak: Hadeel Alkofide (Egilea), Haya M. Almalag (Egilea), Mashael Alromaih (Egilea), Lama Alotaibi (Egilea), Njoud Altuwaijri (Egilea), Noha Al Aloola (Egilea), Jawza F. Alsabhan (Egilea), Ghada A. Bawazeer (Egilea), Lobna Al Juffali (Egilea), Rihaf Alfaraj (Egilea), Nora Alkhudair (Egilea), Raniah Aljadeed (Egilea), Rana Aljadeed (Egilea), Lamya S. Alnaim (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2024-05-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Investigating pharmacovigilance (PV) practices among oncology healthcare providers (HCPs) is crucial for patient safety in oncology settings. This study aimed to assess the awareness, attitudes, and practices towards PV and identify barriers to effective adverse drug reaction (ADR) reporting for HCP...